Table 5.
The AUC values, sensitivities, and specificities for differentiating normal controls (N), benign diseases (B), non-cancers (NC), early stage cancers (E), and late stage cancers (L) based on different panels.
| Compared group | Sex | Panel | AUC | Sensitivity (%) | Specificity (%) | |
|---|---|---|---|---|---|---|
| Lung | NE | M | a | 0.968(.940-.996) | 83.3 | 98.8 |
| F | l | 0.969(.934-1.000) | 90.0 | 94.9 | ||
| BE | M | e | 0.961(.915-1.000) | 86.1 | 100.0 | |
| F | m | 0.807(.695-.919) | 65.0 | 83.3 | ||
| NCE | M | a | 0.957(.926-.989) | 88.9 | 90.8 | |
| F | l | 0.903(.841-.966) | 90.0 | 77.5 | ||
| EL | M | N/A | N/A | N/A | N/A | |
| F | n | 0.700(.568-.832) | 44.2 | 95.0 | ||
| Colorectal | NE | M | a | 0.917(.859-.976) | 80.8 | 89.4 |
| F | b | 0.903(.841-.964) | 81.3 | 87.2 | ||
| BE | M | o | 0.758(.634-.883) | 80.8 | 65.7 | |
| F | i | 0.822(.713-.932) | 84.4 | 73.1 | ||
| NCE | M | a | 0.851(.773-.930) | 73.1 | 87.1 | |
| F | h | 0.902(.842-.962) | 81.3 | 86.5 | ||
| EL | M | N/A | N/A | N/A | N/A | |
| F | N/A | N/A | N/A | N/A | ||
| Gastric | NE | M | b | 0.833(.717-.948) | 76.5 | 83.1 |
| F | d | 1.000(1.000-1.000) | 100.0 | 100.0 | ||
| BE | M | o | 0.740(.587-.893) | 76.5 | 73.7 | |
| F | d | 1.000(1.000-1.000) | 100.0 | 100.0 | ||
| NCE | M | b | 0.801(.690-.913) | 88.2 | 59.2 | |
| F | e | 1.000(1.000-1.000) | 100.0 | 100.0 | ||
| EL | M | p | 0.701(.552-.850) | 78.9 | 64.7 | |
| F | q | 1.000(1.000-1.000) | 100.0 | 100.0 | ||
| Pancreatic | NE | M | a | 0.833(.680-.985) | 75.0 | 80.4 |
| F | r | 0.794(.687-.902) | 100.0 | 71.2 | ||
| BE | M | N/A | N/A | N/A | N/A | |
| F | N/A | N/A | N/A | N/A | ||
| NCE | M | a | 0.775(.629-.921) | 75.0 | 73.3 | |
| F | N/A | N/A | N/A | N/A | ||
| EL | M | N/A | N/A | N/A | N/A | |
| F | N/A | N/A | N/A | N/A | ||
NE, between N and E; BE, between B and E; NCE, between NC and E; EL, between E and L; M, male; F, female.